Top compounds associated with response to GLTSCR1


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.082 0.01
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.01
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.082 0.02
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.02
mRNA BRD-K16147474 CTRPv2 pan-cancer AAC 0.092 0.02
mRNA NSC 74859 CTRPv2 pan-cancer AAC 0.09 0.02
mRNA BRD-K51490254 CTRPv2 pan-cancer AAC 0.087 0.02
mRNA dexamethasone CTRPv2 pan-cancer AAC 0.077 0.02
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.082 0.02
mRNA Doxorubicin gCSI pan-cancer AAC -0.13 0.02
Download CSV